Clinical trials sponsored by Ontario Clinical Oncology Group (OCOG)
4
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 2 1Phase 3 1Not applicable 2
Conditions studied
| Condition | Trials |
|---|---|
| Breast Cancer | 3 |
| Breast Neoplasm Female | 1 |
| Castration Sensitive Prostate Cancer | 1 |
| Cosmetic Outcome | 1 |
| DCIS | 1 |
| Prostate Adenocarcinoma | 1 |
| Prostate cancer | 1 |
| Radiotherapy | 1 |
Recruiting trials led by Ontario Clinical Oncology Group (OCOG)
- A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
- Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
- Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
- Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
Common questions
How many trials is Ontario Clinical Oncology Group (OCOG) recruiting for?
Ontario Clinical Oncology Group (OCOG) is the lead sponsor of 4 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.